Autres langues Shanghai Pharmaceuticals Holding Co., Ltd Other OTC

Actions

SHPMY

US81943R1005

Produits pharmaceutiques

Autres langues

30/06	Shanghai Pharmaceuticals Subsidiary Gets Supplementary Drug Approval for Anti-Organ Rejection Tablets
30/06	Shanghai Pharmaceuticals Gets China Approval for Spasm Drug for Infants
17/06	Shanghai Pharmaceuticals Holding Co., Ltd. Elects Zhao Yong as Employee Representative Director
15/06	Shanghai Pharmaceuticals Gets Nod for Manufacturing of Roxadustat Capsules
12/06	Shanghai Pharmaceuticals Holding Co., Ltd(SHSE:601607) dropped from SSE 180 Index
03/06	Shanghai Pharmaceuticals Holding Co., Ltd Proposes to Pay Cash Dividends in the Half Year of 2026
27/05	Shanghai Pharmaceuticals nominates Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming as exec directors of ninth board session
08/05	Shanghai Pharmaceuticals Gains Thai Approval for Rivaroxaban Tablets
29/04	Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
29/04	Shanghai Pharmaceuticals' Profit Climbs 6.4% in Q1
29/04	Shanghai Pharmaceuticals Holding Q1 net profit up 6.4% Y/Y
28/04	Shanghai United Cell Biotechnology Co., Ltd. agreed to acquire 30% stake in Bristol-Myers Squibb China Pharmaceuticals Co., Ltd. from Shanghai Pharmaceuticals Holding Co., Ltd for CNY 1 billion.
09/04	Shanghai Pharmaceuticals' Tobramycin Sulfate Injection Passes Chinese Drug Regulator's Consistency Evaluation
09/04	Shanghai Pharmaceuticals' Digoxin Tablets Pass Chinese Drug Regulator's Consistency Evaluation
30/03	Shanghai Pharmaceuticals Holding says 2025 net profit up 25.7% Y/Y
30/03	Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
30/03	Shanghai Pharmaceuticals Holding Co., Ltd Recommends Dividend for the Year Ended 31 December 2025, Payable Before 30 August 2026
18/03	Shanghai Pharmaceuticals Passes Generic Drug Evaluation for Antibiotic
25/02	Shanghai Pharmaceuticals Obtains Singapore Marketing Approval for Anticoagulant Drug
11/02	Shanghai Pharmaceuticals Holding Co., Ltd. Announces Election of Zhao Yong as Employee Director, Effective February 11, 2026
05/02	Shanghai Pharmaceuticals Gets Registration Certificate for Sitagliptin/Metformin Tablets
05/02	Shanghai Pharmaceutical to Transfer Sino-American Shanghai Squibb Pharmaceutical for Not Less Than 1.02 Billion Yuan
21/01	Shanghai Pharmaceuticals' Unit Gets Nod for B023 Cell Injection Trial
14/01	Shanghai Pharmaceuticals Lifts Stake in Shanghai Shangshi Group Finance
14/01	Shanghai Pharmaceuticals' Unit Gets Nod for Marketing of Isavuconazole Sulfate API